Pituitary Neuroendocrine Tumor of PIT1-Lineage

Pituitary Neuroendocrine Tumor of PIT1-Lineage — Trials · CancerIndex

Clinical trials

Registered studies

22 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–4 of 4 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03038308	Treatment of Hyperprolactinemia With the Non-ergoline Dopamine Agonist Ropinirole	completed	Phase 1 / Phase 2	16	Columbia UniversityOTHER	1	Jun 4, 2024	clinicaltrials
NCT00939523	Targeted Therapy With Lapatinib in Patients With Recurrent Pituitary Tumors Resistant to Standard Therapy	completed	Phase 2	9	Cedars-Sinai Medical CenterOTHER	1	Jan 22, 2020	clinicaltrials
NCT01620138	Response to Cabergoline and Pasireotide in Non-functioning Pituitary Adenomas and Resistant Prolactinomas	completed	Phase 2 / Phase 3	21	Universidade Federal do Rio de JaneiroOTHER	1	Aug 22, 2016	clinicaltrials
NCT00697814	Clomiphene in Males With Prolactinomas and Persistent Hypogonadism

Data updated 22 days agoSource updated Jun 4, 2024source: clinicaltrials